Allogeneic antigen presenting cells for immunotherapy - sDCord® -

Boosting the immune system for higher efficacy of standard cancer therapies.

3196301 ml

sDCord® are antigen presenting cells generated from hematopoietic stem and progenitor cells using a specific modification of Glycostem's basic cell production platform technology. Different subsets of dendritic cells (DCs) are under preclinical development.

sDCord® can be used as standalone treatment to boost patients own immune system or in combination with oNKord® to benefit patients with a dual mode of action.